Evidence map›Paper›PMID 34183850›Full record

ArticleNature metabolism2021

Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetes.

Leonore Wigger, Marko Barovic, Andreas-David Brunner, Flavia Marzetta, Eyke Schöniger, Florence Mehl, Nicole Kipke, Daniela Friedland, Frederic Burdet, Camille Kessler and 17 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Nature metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 1 pooled it
23.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 1 synthesis or guideline pooled it, 156 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Identification of Biomarkers forCurrent issues in molecular biology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Contrasting Effects of Chronic Glucokinase Activation and Inhibition on Pancreatic Beta-Cell Function.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  18. Article
  19. Article
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 9 institutions in 5 countries.

Leonore Wigger *Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.ORCID http://orcid.org/0000-0001-5230-0265
Marko Barovic *Department of Molecular Diabetology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0002-0839-6009
Andreas-David Brunner *Max Planck Institute of Biochemistry, Martinsried, Germany.
Flavia MarzettaVital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Eyke SchönigerDepartment of Molecular Diabetology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Florence MehlVital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-9619-1707
Nicole KipkeDepartment of Molecular Diabetology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Daniela FriedlandDepartment of Molecular Diabetology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Frederic BurdetVital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Camille KesslerVital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Mathias LescheDRESDEN-concept Genome Center, c/o Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0002-3274-7163
Bernard ThorensCenter for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-3738-0129
Ezio BonifacioPaul Langerhans Institute Dresden (PLID), Helmholtz Center Munich, University Hospital and Faculty of Medicine, TU Dresden, Dresden, Germany.
Cristina Legido-QuigleySteno Diabetes Center Copenhagen, Gentofte, Denmark.
Pierre Barbier Saint HilaireDMPK Center, Technologie Servier, Orléans, France.
Philippe DeleriveInstitut de Recherches Servier, Pôle d'Innovation Thérapeutique Métabolisme, Suresnes, France.
Andreas DahlDRESDEN-concept Genome Center, c/o Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0002-2668-8371
Christian KloseLipotype GmbH, Dresden, Germany.
Mathias J GerlLipotype GmbH, Dresden, Germany.ORCID http://orcid.org/0000-0002-8074-7221
Kai SimonsLipotype GmbH, Dresden, Germany.
Daniela AustDepartment of Pathology, Medical Faculty, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Jürgen WeitzDepartment of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Medical Faculty, Technische Universität Dresden, Dresden, Germany.
Marius DistlerDepartment of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Medical Faculty, Technische Universität Dresden, Dresden, Germany.
Anke M SchulteSanofi-Aventis Deutschland GmbH, Diabetes Research, Industriepark Höchst, Frankfurt am Main, Germany.
Matthias MannMax Planck Institute of Biochemistry, Martinsried, Germany. mmann@biochem.mpg.de.ORCID http://orcid.org/0000-0003-1292-4799
Mark IbbersonVital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland. Mark.Ibberson@sib.swis.ORCID http://orcid.org/0000-0003-3152-5670
Michele SolimenaDepartment of Molecular Diabetology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany. Michele.Solimena@uniklinikum-dresden.de.ORCID http://orcid.org/0000-0002-3653-8107
SIB Swiss Institute of Bioinformatics · CHDeutsches Diabetes-Zentrum e.V. · DECenter for Systems Biology Dresden · DEUniversity Hospital Carl Gustav Carus · DEMax Planck Institute of Biochemistry · DEServier (France) · FRSanofi (Germany) · DESteno Diabetes Centers · DKUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most research on human pancreatic islets is conducted on samples obtained from normoglycaemic or diseased brain-dead donors and thus cannot accurately describe the molecular changes of pancreatic islet beta cells as they progress towards a state of deficient insulin secretion in type 2 diabetes (T2D). Here, we conduct a comprehensive multi-omics analysis of pancreatic islets obtained from metabolically profiled pancreatectomized living human donors stratified along the glycemic continuum, from normoglycemia to T2D. We find that islet pools isolated from surgical samples by laser-capture microdissection display remarkably more heterogeneous transcriptomic and proteomic profiles in patients with diabetes than in non-diabetic controls. The differential regulation of islet gene expression is already observed in prediabetic individuals with impaired glucose tolerance. Our findings demonstrate a progressive, but disharmonic, remodelling of mature beta cells, challenging current hypotheses of linear trajectories toward precursor or transdifferentiation stages in T2D. Furthermore, through integration of islet transcriptomics with preoperative blood plasma lipidomics, we define the relative importance of gene coexpression modules and lipids that are positively or negatively associated with HbA1c levels, pointing to potential prognostic markers.

Indexed as

BiomarkersBlood GlucoseDiabetes Mellitus, Type 2Disease SusceptibilityEnergy MetabolismGene Expression ProfilingGene Expression RegulationHumansInsulinInsulin-Secreting CellsIslets of LangerhansLiving DonorsMetabolomicsProteomicsBiomarkersBlood GlucoseInsulin

Identifiers

PMID34183850
OpenAlexW3175623102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.